Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option
★★★★★ 3rd-party
External rating
- Source: Third-party data provider (Groww/CRISIL)
- Original rating: 4/5, displayed as-is — TopFund does not modify third-party ratings
- Refresh frequency: Whenever TopFund re-syncs this fund's data
- Limitations: The provider's own rating methodology isn't disclosed here — see the provider's own site for their criteria
TopFund Score: 79/100 · Good
How this score is calculated
- Star rating (35%)4/5
- 3Y CAGR (30%)22.4%
- Expense ratio (20%)1.32%
- AUM (15%)₹6,803 Cr
Not investment advice — an analytical read of public fund data. Methodology →
ICICI Prudential Mutual Fund · Equity · Sectoral
₹46.88
AUM: ₹6,802 Cr
NAV updated 19 days ago
Plan
Direct
Option
Growth
Risk
Very High
Expense Ratio
1.32%
Exit Load
Exit load of 1% if redeemed within 15 days.
Fund Manager
Ihab Dalwai, Priyanka Khandelwal
Inception
Jul 2018
Benchmark
BSE Healthcare Total Return Index
Sharpe Ratio
0.48
Std Dev (1Y)
13.04%
Historical Returns (CAGR)
Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.
1m
-1.84%
3m
+5.59%
6m
+14.04%
1y
+9.02%
3y
+22.4%
5y
+16.01%
10y
—
since inception
+21.03%
TopFund's Take on ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option holds up reasonably well within the Sectoral category, backed by a 4-star rating. Consistent 3-year performance combined with a strong rating makes this one of the more credible options in its space. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 79/100.
Cost: At 1.32%, the expense ratio runs 33% above the Sectoral category average of 0.99%. That gap is worth weighing against the fund's actual performance versus cheaper peers before committing to a long SIP.
Risk-adjusted performance: Over the trailing 1-year period, the fund shows a modest Sharpe ratio of 0.48 — returns have only marginally compensated for the risk taken. Separately, annualised volatility of 13.04% is fairly typical for Sectoral funds.
Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Equity fund. Given the Very High risk rating, this fund is not suited to short-term goals or investors who may need to exit within 2-3 years.
This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.
Sector Allocation
Asset Allocation
Fund Snapshot
Similar Funds
DSP Nifty Healthcare Index Fund - Direct- Growth
DSP Mutual Fund
quant BFSI Fund - Growth Option - Direct Plan
Quant Mutual Fund
DSP Nifty Bank Index Fund - Direct - Growth
DSP Mutual Fund
Invesco India Financial Services Fund - Direct Plan - Growth
Invesco Mutual Fund
BANK OF INDIA Manufacturing & Infrastructure Fund-Direct Plan-Growth
Bank of India Mutual Fund
Bandhan BSE Healthcare Index Fund Direct Plan - Growth
Bandhan Mutual Fund
Tools & Guides for This Fund
Frequently Asked Questions about ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option
The current NAV (Net Asset Value) of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option is ₹46.88. NAV is updated every business day after market close by AMFI.
1Y: 9.02% · 3Y CAGR: 22.4% · 5Y CAGR: 16.01%
The expense ratio of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option is 1.32% per annum. This is the annual fee charged by the fund to manage your investment.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option is managed by Ihab Dalwai, Priyanka Khandelwal at ICICI Prudential Mutual Fund.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option is classified as a Very High risk fund. It is suitable for aggressive investors with a long-term horizon of 5+ years.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option is a Sectoral fund. SIP suitability depends on your investment goal and risk profile.
You can start a SIP in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option with as little as ₹500 per month through most mutual fund platforms. The minimum lump sum investment is typically ₹1,000.
The Assets Under Management (AUM) of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option is ₹6,803 crore. AUM indicates the total market value of assets managed by the fund.
* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.
Discussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.